Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis

NCT06328075 is registered in ClinicalTrials.gov with Algalarrondo Vincent as lead sponsor.

NCT NCT06328075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06328075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis
Lead sponsor
Algalarrondo Vincent
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
January 1, 2026
Enrollment
15,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloid cardiomyopathy, transthyretin amyloid cardiomyopathy, transthyretin cardiac amyloidosis